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Implementation mechanisms of psychosomatic disorders in gastroesophageal 
reflux disease with concomitant chronic obstructive pulmonary disease 
 
Mehanizmi za realizaciju psihosomatskih poremećaja kod gastroezofagealne refluksne 
bolesti s komorbidnom kroničnom opstruktivnom bolešću pluća 
 






Nowadays, gastroesophageal reflux diseases and chronic obstructive pulmonary diseases are among the 
most commonly occurring diseases. In most cases these diseases occur combined. Considering the fact that 
psychosomatic disorders play a major role in the formation of gastroesophageal reflux diseases and chronic 
obstructive pulmonary diseases, researching their implementation with the combined course of these 
diseases represents scientific and practical interest. Therefore, the aim of our research was to investigate the 
mechanisms of implementation of psychosomatic disorders in this comorbidity. During our research, we 
took two groups of patients. The first group consisted of patients with gastroesophageal reflux disease 
combined with chronic obstructive pulmonary disease. The second group consisted of patients with isolated 
gastroesophageal reflux disease. In addition to the standard methods of research, gastroesophageal reflux 
disease and chronic obstructive pulmonary disease, the level of melatonin, norepinephrine, and 
psychosomatic status indicators were also researched. As a result, it was found that patients with comorbid 
pathology had significantly higher indicators of depression, but indicators of melatonin and respiratory 
function significantly lower not only with persons in the control group, but also in patients with isolated 
gastroesophageal reflux disease. At the same time, patients with gastroesophageal reflux disease without 
comorbidity pathology had significantly higher indicators of reactive and personal anxiety, norepinephrine, 
and pH meters not only in the control group, but also in comparison with gastroesophageal reflux disease 
patients with concomitant chronic obstructive pulmonary disease. Thus, the obtained results indicate that 
patients with gastroesophageal reflux disease combined with concomitant chronic obstructive pulmonary 
disease have psychosomatic disorders, primarily due to depressions, that lead to the decreasing of melatonin 
levels and external respiration parameters which leads to the reduction of protective properties of the 
esophagogastric junction. Psychosomatic disorders of patients with isolated gastroesophageal reflux disease 
lead to increased production of norepinephrine and hydrochloric acid, first of all, due to increasing reactive 
and personal anxiety level, and thereby contribute to the increase in aggression factor level. The acquired 
data testify the role of psychosomatic disorders in creating the basic and accompanying pathology which 
requires differentiated treatment, aimed at increasing of protective properties of the first group of patients, 
and reducing aggression factors of the second group of patients. 
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Gastroezofagealna refluksna bolest i kronična opstruktivna bolest pluća najčešće su bolesti koje se u 
značajnom postotku javljaju zajedno. S obzirom da psihosomatski poremećaji igraju veliku ulogu, kako u 
formiranju gastroezofagealne refluksne bolesti, tako i kronične opstruktivne bolesti pluća, proučavanje 
njihove pojave predstavlja znanstveno-primijenjeni interes. Stoga je cilj našega istraživanja proučavanje 
mehanizama utjecaja psihosomatskih poremećaja u ovoj komorbidnoj patologiji. Tijekom našeg istraživanja 
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uzeli smo dvije skupine bolesnika. Prvu skupinu čine bolesnici koji pate od gastroezofagealne refluksne 
bolesti, uz prateću kroničnu opstruktivnu bolest pluća, a drugu oni s izoliranom gastroezofagealnom 
refluksnom bolešću. Osim standardnih metoda istraživanja gastroezofagealne refluksne bolesti i kronične 
opstruktivne bolesti pluća, provedena su istraživanja razine melatonina, noradrenalina, te pokazatelja 
psihosomatskog statusa kod bolesnika. Kao rezultat provedenih istraživanja utvrđeno je da su kod bolesnika 
s komorbidnom patologijom pokazatelji depresije bili značajno veći, a pokazatelji melatonina i funkcije 
disanja znatno niži, ne samo kod osoba kontrolne grupe, nego i kod bolesnika s izoliranom 
gastroezofagealnom refluksnom bolešću. U isto vrijeme, kod bolesnika s gastroezofagealnom refluksnom 
bolešću bez komorbidne patologije, pokazatelji reaktivne i osobne anksioznosti, noradrenalina i ph-metara 
bili su značajno viši, ne samo kod kontrolne grupe, nego i kod bolesnika gastroezofagealne refluksne bolesti 
s komorbidnom kroničnom opstruktivnom bolešću pluća. Dobiveni rezultati pokazuju da je kod bolesnika 
od gastroezofagealne refluksne bolesti s kroničnom opstruktivnom bolešću pluća, psihosomatski poremećaj, 
prvenstveno depresija, doveo do smanjene razine melatonina i pokazatelja funkcije disanja, te smanjenja 
zaštitnih svojstava ezofago-gastričnog sfinktera. Kod bolesnika s izoliranom gastroezofagealnom 
refluksnom bolešću, psihosomatski poremećaji dovode do povećanja razine noradrenalina i klorovodične 
kiseline, tj. doprinose povećanju čimbenika agresije, prvenstveno kroz povećanje pokazatelja reaktivne i 
osobne tjeskobe. Dobiveni podaci svjedoče o ulozi psihosomatskih poremećaja u formiranju, kako osnovne, 
tako i popratne patologije, što zahtijeva diferenciranu terapiju koja je usmjerena na bolesnika iz prve skupine 
za povećanje zaštitnih svojstava, a iz druge skupine na smanjenje čimbenika agresije. 
Ključne riječi: gastroezofagealna refluksna bolest, kronična opstruktivna bolest pluća, psihosomatski 








The problem of comorbid pathology is one of the 
leading ones in modern medicine today.
1-2
 The most 
frequent diseases, which usually occur combined with 
other pathology, are gastroesophageal reflux disease 
(GERD) and chronic obstructive pulmonary disease 
(COPD).
3-6
 The prevalence of such comorbid diseases 
in the Asian continent, according to the data of Jinhee 
et all, is up to 28%,
7
 in America, according to the data 
of Smith and Wrobel from 7.7% to 30%
4
, and in 
Western Europe, according to Velanovich from 3% to 
16%.
8
 In their turn, these diseases are the most 
prevalent among the structure of diseases of the 
gastrointestinal tract from 20% to 60%, and of the 
respiratory organs from 10% to 25% respectively.
9-11
 
A particular problem is the pathogenesis of the 
combined course of GERD and COPD.
12-14
 Moreover, 
the question of which disease is primary and which 
develops on its background is still being studied.
15-18
 
At the same time, many medications, which are         
used during the treatment of COPD, particularly, 
theophylline and inhalation forms of glucocortico-
steroids and adrenomimetics, have a negative effect 




Thus, researches of common pathogenic mecha-
nisms, that create the basis for GERD and COPD, 
will contribute not only to the discovery of their 
pathogenesis, but also the development of therapy, 
considering these common pathogenetic compo-
nents.
21
 Considering that psychosomatic disorders 
play an important role in the formation of GERD
22
 by 
regulating the motor and secretory function of the 
digestive tract, as well as in the formation of COPD
23
 
by regulating the processes of the bronchial tree tone, 
the study of the features of their pathological 
implementation in case of comorbidity will be of 
scientific interest and practical importance. 
The main goal of the research is to examine the 
role of psychosomatic disorders in the mechanism of 
formation of GERD with concomitant COPD.  
 
Materials and methods of research 
 
Proceeding from the stated objective, we took two 
groups of patients. The first group of patients 
consisted of 40 people (18 women and 22 men) aged 
from 20 to 35, who were sick with nonerosive GERD 
with concomitant COPD of I-II degree. Patients with 
the other concomitant disease were not included in 
the study. The second group included 45 patients (26 
men and 19 women) aged from 19 to 33 years, who 
were sick with nonerosive form of GERD without 
comorbidity. The control group consisted of 20 
almost healthy persons of the same age and sex.  
During the study, an examination of young 
patients with GERD was performed on clinical basis 
of the Department of Therapy, Rheumatology and 
Clinical Pharmacology of the Kharkov Medical 
Academy of Postgraduate Education. The research 
was approved by the Institutional Ethics Committee 
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of the Kharkov Medical Academy of Postgraduate 
Education and Clinical Bases. Written informed 
consent was obtained from all the study subjects. The 
GERD diagnosis was established in accordance with 
ICD-10, considering the Montreal Consensus 2006 
and Gstaad guidelines for GERD treatment.  
To validate the GERD diagnosis, patients were 
subjected to endoscopy by fibergastroscope Olympus 
XP-20 (made in Japan), intragastric pH monitoring, 
performed on acidogastrometer (indicator of acidity 
of the stomach) "Gastric acidity indicator – 2" (made 
in Ukraine), and GERD questionnaire. The diagnosis 
of COPD was validated according to ICD-10, and 
considering recommendations of Global initiative for 
obstructive lung diseases (GOLD) 2016. External 
breathing function was defined using spirograph 
(produced in Ukraine) by standard methodics.          
During the spirography, pharmacological tests were 
performed with a short-acting bronchodilator to 
determine its influence on lung function. To avoid 
distortions of bronchodilation test results patients 
stopped using bronchodilators in accordance with the 
pharmacological properties of used drug. 
The level of melatonin in blood serum was 
determined by ELISA, using the reagents from the 
IBL standard kit (made in Germany). The level of 
norepinephrine in blood plasma was determined by 
ELISA, using the reagents from the IBL standard kit 
(made in Germany). 
The psychosomatic condition of patients was 
determined by Spielberg's questionnaire of personal 
and reactive anxiety, Beck depression questionnaire, 
Eysenck personality questionnaire, which allows            
to determine the features of a patient's character: 
extrovert, introvert, neurotic, Sheehan anxiety 
questionnaire. 
The results were processed by methods of 
variation statistics using PC software Statystyka. Data 
were presented in a conventional form of (M ± m), 
where M – the arithmetic average, and m – the error 
of arithmetic average. The results were considered 
statistically significant when the probability of error 
was less than 5% (p < 0.05). To analyze the 
significance of differences between two groups was 
used ± (Student’s t-test). As required to compare the 
values of the indicator inside two or more groups 
simultaneously, analysis of variance with the 




The research resulted in both groups having 
significant change of psychosomatic status compared 
with the individuals of the control group. Patients 
with GERD concomitant COPD had indicators of 
depression 35.7 ± 2.1 points and patients with GERD 
without comorbidity had 26.8 ± 1.9 points at norm or 
rate 8.1 ± 1.1 points. Simultaneously, the patients of 
the first group indicated reactive and personal anxiety 
values 39.7 ± 0.91 and 38.4 ± 1.05 points at norm or 
rate 22.7 ± 1.4 and 23.5 ± 1.3 points. At the same 
time, patients with GERD without comorbidity, 
indicated reactive and personal anxiety values 43.4 ± 
0.85 and 45.8 ± 1.6 points respectively. Patients with 
GERD concomitant COPD had indicators of trouble 
52.4 ± 2.8 points, patients with isolated GERD had 
45.27 ± 2.7 points. The level of the trouble indicators 
in the control group was 19.5 ± 1.4 points (Table 1). 
It was thus registered that patients with GERD 
concomitant COPD revealed a significant increase in 
depression and anxiety level not only compared with 
the control group, but compared also with GERD 
patients without comorbidity. 
 
Table 1 Indicators of psychosomatic status in GERD patients with concomitant COPD and without 
comorbidity. 












35.7 ± 2.1 26.8 ± 1.9 8.1 ± 1.1 
Reactive anxiety 
Reaktivna tjeskoba 
39.7 ± 0.91 43.4 ± 0.85 22.7 ± 1.4 
Personal anxiety 
Osobna tjeskoba 
38.4 ± 1.05 45.8 ± 1.6 23.5 ± 1.3 
Trouble 
Nevolja  
45.27 ± 2.7 52.4 ± 2.8 19.5 ± 
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At the same time, patients with GERD without 
comorbidity indicators of reactive and personal 
anxiety were significantly higher compared not only 
with the indicators of the control group, but also 
compared with indicators of patients with GERD with 
concomitant COPD. The trouble level indicators were 
significantly higher inside the group of patients with 
isolated GERD comparing both with the indicators of 
the GERD patients group with concomitant COPD 
and with the control group. It was also found that 
among patients with GERD with concomitant COPD, 
the majority were introverts (57%), while in patients 
with GERD without comorbidity dominated extroverts 
(32%) and neurotics (49%). 
In researching the melatonin level, it was found 
that the first group of patients had average values  7.8 
± 0.9 pg/ml and at the second group of patients 14.8 ± 




Picture. 1 Indicators of serum melatonin (pg / ml) in 
patients with GERD concomitant COPD, with 
isolated GERD and in the control group 
Slika 1. Pokazatelji melatonin seruma (pg/ml) kod 
pacijenata s GERD popratnim COPD s izoliranim 
GERD i u kontrolnoj skupini 
 
Thus, it was noted that patients with GERD with 
concomitant COPD had a significant decrease in 
melatonin level, compared with a control group of 
persons, and patients with GERD without conco-
mitant pathology. Along with this, the melatonin level 
of the second group patients was statistically signifi-
cantly lower than with the controlled individuals. 
Analyzing the norepinephrine level, it was found 
that patients of the first treatment group had average 
value 375.7 ± 6.8 pg / ml and patients with GERD 
without comorbidity 477.9 ± 8.1 pg/ml at the 
established normal rate 264.7 ± 6.3 pg/ml (Picture 
2). Thus, patients with GERD concomitant COPD 
indicators of norepinephrine had significantly lower 
indicators values, compared with patients with 
GERD without comorbidity (p < 0.001), though 
these indicators were significantly higher in the 
control subjects (p < 0.001). 
 
 
Picture 2 Indicators of norepinephrine levels in the 
blood plasma (pg/ml) in GERD patients with 
concomitant COPD, without comorbidities, and 
control group 
Slika 2. Pokazatelji razina norepinefrina u krvnoj 
plazmi (pg/ml) kod GERD pacijenata s popratnim 
COPD, bez komorbiditeta i kontrolna skupina 
 
Analyzing spirography data, it was found that 
patients of the first group had a more distinct decrease 
in the respiratory function as compared with those in 
the control group and patients with GERD without 
comorbidity. Index FEV1 averaged 63.82 ± 2.70% at 
a rate of 96.7 ± 3.2% and 73.25 ± 3.1% of GERD 
patients without comorbidity. Indicators FEV1 / FVC 
in patients of the first group was 62.48 ± 1.57% at a 
rate of 85.2 ± 2.3% and 71.51 ± 1.91% of GERD 
patients without comorbidity. Indicators MOS and 
MOS 25% to 50% of the first group patients 
amounted, on average, 38.24 ± 2.31 l / sec and 33.21 
± 2.42 l / sec, whereas with the second group of 
patients the figures were 47.25 ± 2.32 l /sec. and 
41.38 ± 2.37 l/sec. at a rate of 97.7 ± 2.61 l/sec. and 
83.5 ± 2.29 l / sec (Picture 3).  
The acidity of the gastric juice in the corpus of the 
first group patients averaged 1.3 ± 0.11 at a rate of 1.8 
± 0.21 and 0.95 ± 0.12 in the second group of patients. 
Acidity indicators in the antrum in patients with the 
first group averaged 4,5 ± 0,31 at a rate of 7,1 ± 0,35 





























   First group         Second group      Control group 
 Prva skupina       Druga skupina     Treća skupina 
 First group      S  group    Control group 
 Prva skupina   D uga skupina  Treća skupina 






Picture 3 Indicators of external respiration function in GERD patients with concomitant COPD,                         
without comorbidities and control group 
Slika 3. Pokazatelji vanjske respiratorne funkcije kod GERD pacijenata s popratnim COPD  





Picture 4 Indicators of gastric acidity in the corpus and antrum in GERD patients with concomitant COPD, 
without comorbidities and control group 
Slika 4. Pokazatelji želučane kiseline u korpusu i antrumu kod GERD pacijenata s popratnim COPD  
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рН gastric acid in 
the corpus 
рН gastric acid in 
the antrum 
     First group             Second group          Control group 
   Prva skupina           Druga skupina         Treća skupina 
                      First group      Second group     C ntrol group 
                     Prva skupina    Druga skupina    Treća skupina 
pH gastric acid in the corpus 




pH gastric acid in the antrum 
pH želučana kiselina u antrumu 
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Analyzing the correlation, the following was 
detected. GERD patients with concomitant COPD 
degree of manifestation of psychosomatic disorders, 
and especially indicators of depression, were in close 
correlation (r = 0.75) with the level of melatonin and 
indicators of respiratory function. The higher was the 
level of psychosomatic disorders the lower were the 
level of melatonin and indicators of respiratory 
function. Patients with isolated GERD had a clear 
correlation (R = 0.73) between the severity of 
psychosomatic disorders, primarily reactive and 
personal anxiety, with higher levels of norepinephrine 




Our results on the prevalence and severity of 
GERD with concomitant COPD found confirmation 
in the works of Lee et al.
12
 The authors examined the 
prevalence of symptomatic and clinically silent 
proximal and distal gastroesophageal reflux (GER) in 
adults with chronic obstructive pulmonary disease 
(COPD) and gastric aspiration. The prevalence of 
GERD in COPD was 37%. Of those diagnosed with 
GERD, clinical reflux was detected in 20% patients 
with COPD.  
Psychosomatic disorder researches with a 
combination of GERD with COPD have been the 
subject of several works.
5,24,25
 One of the latest works 
was conducted by Smith and Wrobel,
4
 where the 
authors have shown the influence of psychosomatic 
disorders, such as depression and anxiety, on the 
worsening of COPD and GERD courses. However, as 
in other similar works, authors have not studied how 
these psychosomatic changes affect the acidity and 
lung function.  
The correlation of melatonin level inpatients with 
psychosomatic disorders has been described in the 
work of Nagane et al.
26
 In this work, it is noted that 
circadian rhythm disorders have effect on the 
presence and severity of psychosomatic disorders, 
and evidenced by a decrease of melatonin levels in 
the test group. However, these works were not 
devoted to the study of the level of melatonin and 
psychosomatic disorders in any particular disease.  
The level of noradrenaline, along with the 
presence of psychosomatic disorders in middle-aged 
females, was studied by Hughes et al.
27
 Ninety-one 
women aged 47-55 years were evaluated in this study. 
Depression symptoms were assessed with the Beck 
Depression Inventory and state anxiety was assessed 
with the state anxiety portion of the Spielberger State-
Trait Anxiety Inventory. Twenty-four-hour urine 
collections were assayed for epinephrine, norepine-
phrine and cortisol. These results suggested that 
higher levels of depression symptoms on a scale Beck 
(≥ 10) and state anxiety on Spielberg questionnaire 
were associated with increased 24-hour 
norepinephrine excretion (r = .27. P = .009) and (r = 
0.28, P = 0.01), respectively. The current findings 
suggest that depression and anxiety may be associated 
with increased sympathetic nervous system activity 
and, in particular, with the level of noradrenaline.  
Finding the pathophysiological mechanisms of 
depression and anxiety were the task of Paine et al. 
research.
28
 This research involved 140 patients with 
average age 45.5 years; females accounted for 38.5%. 
Research was performed on the concentration of 
noradrenaline in daily urine, as indicator of activity of 
the simpatoadrenal system. Depressive symptoms 
were assessed using the Beck Depression Inventory, 
with anxiety symptoms assessed using the Spielberger 
State-Trait Anxiety Inventory.  
It has been shown that the points of depression and 
anxiety were intercorrelated (R = 0.76, p < 0.001), 
and the noradrenaline level of daily urine correlated 
with anxiety (R = 0.10, p = 21) and depression (r = 
0.07, p = 0.39). As a conclusion, authors determined 
that anxiety was associated with heightened 
sympatho-adrenal activity, suggesting a biological 
pathway through which anxiety could increase the 
risk of internal diseases.  
Thus, the analysis of recent works demonstrates a 
clear relationship of psychosomatic disorders with the 
contents of melatonin and noradrenaline. And, at the 
same time, a noticeable lack of true researches of 
these indicators in patients with comorbid disorders of 
GERD and COPD and definition of their role in the 
pathogenesis of these diseases. This was the aim of 
our research.  
Analysis of research results conducted by us 
shows that GERD patients with concomitant COPD 
had psychosomatic disorders primarily at the expense 
of depression, leading to decreasing melatonin level 
and external respiration parameters. This led to a 
reduction of the protective properties of the 
esophagogastric junction. Patients with isolated 
GERD, psychosomatic disorders, first of all, due to 
increasing of reactive and personal anxiety, led to the 
increased production of norepinephrine and 
hydrochloric acid and thereby contributed to an 
increase of the aggression factor. Data obtained 
during research evidenced the role of psychosomatic 
disorders during the formation of both diseases: the 
main and concomitant and required differentiated 
treatment, aimed at patients of the first group to 
improve the protective properties, while in the second 
group of patients to reduce aggression factors. 





It was detected that both groups under research 
had significant psychosomatic disorders, compared 
with the control group. GERD patients with 
concomitant COPD had depression indicators that 
were significantly higher (35,7 ± 2,1) compared with 
indicators of the control group (8.1 ± 1.1) and 
GERD patients without comorbidity (26.8 ± 1.9). 
Reactive and personal anxiety indicators of GERD 
patients without comorbidity were significantly 
higher (43.4 ± 0.85 and 45.8 ± 1.6) than the 
indicators of the control group (22.7 ± 1,4 and 23.5 
± 1.3) and the indicators of the GERD with 
concomitant COPD group (39.7 ± 0.91 and 38.4 ± 
1.05). At the same time, indicators of trouble were 
significantly higher in group patients with isolated 
GERD (52.4 ± 2.8) than the indicators of the control 
group (19.5 ± 1.4) and the indicators of the group 
with the GERD concomitant COPD (45.27 ± 2.7).  
It was found that GERD patients with conco-
mitant COPD (7.8 ± 0.9 pg/ml) had significantly 
decreased melatonin level, as compared with the 
norm (22.3 ± 1.4 pg/ml), as with patients without 
GERD comorbidity (14.8 ± 1.2 pg/ml). Patients with 
comorbid disorder indicators of norepinephrine 
levels were significantly higher (375.7 ± 6.8 pg/ml), 
than normal (264.7 ± 6.3 pg/ml) but significantly 
lower than the level of norepinephrine of GERD 
patients without comorbidity (477.9 ± 8.1 pg/ml).  
Patients with GERD with concomitant COPD 
indicators of respiratory function were significantly 
lower (OFV1 – 63.82 ± 2.70%, OFV1/FVC – 62.48 
± 1.57%, МОS 25% – 38.24 ± 2.31 l/sec, МОS 50% 
– 33.21 ± 2.42 l/sec) than indicators of the control 
group (OFV1 – 96.7 ± 3.2%, OFV1/FVC – 85.2 ± 
2.3%, МОS 25% – 97.7 ± 2.61 l/sec, МОS 50% – 
83.5 ± 2.29 l/sec) and GERD without comorbidity 
patients (OFV1 – 73.25 ± 3.1%, OFV1/FVC – 71.51 
± 1.91%, МОS 25% – 47.25 ± 2.32 l/sec, МОS 50% 
– 41.38 ± 2.37 l/sec). Patients with GERD without 
comorbidity indicators of gastric acidity in the 
corpus were significantly higher (0.95 ± 0.12) than 
the control group (1.8 ± 0.21) and GERD patients 
with concomitant COPD (1.3 ± 0.11). The highest 
indicators of gastric acidity in the antrum were in the 
group of patients with GERD concomitant COPD 
(4.5 ± 0.31), while in the second group (4.5 ± 0.31) 
these indicators were approaching the control group 
indicators (7.1 ± 0.35). 
It was revealed that a clear correlation was 
established among the severity of psychosomatic 
disorder, the prevalence of increased depression 
level in patients, indicators of reactive and personal 
anxiety, indicators of respiratory function, of pH 
levels, increasing the level of melatonin and 
norepinephrine. The last is indicative for those 
GERD patients with concomitant COPD due to 
psycho-somatic disorders leading to decreasing 
melatonin level and indicators of respiratory 
function. This led to decreasing protection factors of 
esophagogastric junction (r = 0.75). Patients with 
isolated GERD, due to increased reactive and 
personal anxiety, had higher levels of norepine-
phrine, gastric pH. It meant that it led to the 
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